~~<i id='E440D9A31B'><strike id='E440D9A31B'><tt id='E440D9A31B'><pre id='E440D9A31B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：comprehensive 2025-09-02 11:48:01 - browse：45

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

focus

hotspot

Wikipedia

hotspot

leisure time

KristofferTripplaar/APThedruggiantEliLillysaidThursdaythatitsdiabetesdrugMounjarohelpedpatientswitht

WSS

Ransomware attacks on hospitals: Study outlines patient impact

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Timeline: Key moments in fight for gay rights

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

FDA approves first new drug developed for postpartum depression

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

knowledge

hotspot

hotspot

Peter Hotez and the public health issue of online harassment

How to fix the rural physician shortage in the U.S.

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Medical records are filled with copy

Millions may soon lose Medicaid when they don't have to

Trump demands the U.S. pay no more for drugs than other countries … again

Sea level rise could wash away turtle breeding grounds around the world, researchers say

The high cost of giving birth even with insurance

A daunting task: navigating dual Medicare, Medicaid eligibility

focus

Can medical device makers keep up in the race to treat obesity?

Does good food count as health care? Study aims to find out

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Inside the rise of 'mukbang' eating videos

Eli Lilly’s Mounjaro succeeds in second weight

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

hotspot

Wikipedia

hotspot

leisure time